[HTML][HTML] Emerging therapeutic strategies for Parkinson's disease and future prospects: A 2021 update
NA Gouda, A Elkamhawy, J Cho - Biomedicines, 2022 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disorder pathologically distinguished by
degeneration of dopaminergic neurons in the substantia nigra pars compacta. Muscle …
degeneration of dopaminergic neurons in the substantia nigra pars compacta. Muscle …
Understanding the links between cardiovascular disease and Parkinson's disease
Studies investigating the associations between genetic or environmental factors and
Parkinson's disease (PD) have uncovered a number of factors shared with cardiovascular …
Parkinson's disease (PD) have uncovered a number of factors shared with cardiovascular …
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
K Senkevich, Z Gan-Or - Parkinsonism & related disorders, 2020 - Elsevier
In recent years, multiple lines of evidence from human genetic and molecular studies have
highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's …
highlighted the importance of the autophagy lysosomal pathway (ALP) in Parkinson's …
The vicious cycle between αsynuclein aggregation and autophagiclysosomal dysfunction
G Bellomo, S Paciotti, L Gatticchi… - Movement …, 2020 - Wiley Online Library
The accumulation and misfolding of αsynuclein (αsyn) represent the main pathological
hallmark of PD. Overexpression of αsyn and failure of cellular protein degradation systems …
hallmark of PD. Overexpression of αsyn and failure of cellular protein degradation systems …
[HTML][HTML] The relationship of alpha-synuclein to mitochondrial dynamics and quality control
NJ Thorne, DA Tumbarello - Frontiers in molecular neuroscience, 2022 - frontiersin.org
Maintenance of mitochondrial health is essential for neuronal survival and relies upon
dynamic changes in the mitochondrial network and effective mitochondrial quality control …
dynamic changes in the mitochondrial network and effective mitochondrial quality control …
Variants in saposin D domain of prosaposin gene linked to Parkinson's disease
Y Oji, T Hatano, SI Ueno, M Funayama, K Ishikawa… - Brain, 2020 - academic.oup.com
Recently, the genetic variability in lysosomal storage disorders has been implicated in the
pathogenesis of Parkinson's disease. Here, we found that variants in prosaposin (PSAP), a …
pathogenesis of Parkinson's disease. Here, we found that variants in prosaposin (PSAP), a …
Delivering the promise of gene therapy with nanomedicines in treating central nervous system diseases
Abstract Central Nervous System (CNS) diseases, such as Alzheimer's diseases (AD),
Parkinson's Diseases (PD), brain tumors, Huntington's disease (HD), and stroke, still remain …
Parkinson's Diseases (PD), brain tumors, Huntington's disease (HD), and stroke, still remain …
Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond
AN Bayne, JF Trempe - Cellular and Molecular Life Sciences, 2019 - Springer
Parkinson's disease (PD) is a degenerative movement disorder resulting from the loss of
specific neuron types in the midbrain. Early environmental and pathophysiological studies …
specific neuron types in the midbrain. Early environmental and pathophysiological studies …
[HTML][HTML] Alpha-synuclein and lipids: the elephant in the room?
A Sarchione, A Marchand, JM Taymans… - Cells, 2021 - mdpi.com
Since the initial identification of alpha-synuclein (α-syn) at the synapse, numerous studies
demonstrated that α-syn is a key player in the etiology of Parkinson's disease (PD) and other …
demonstrated that α-syn is a key player in the etiology of Parkinson's disease (PD) and other …
[HTML][HTML] A practical approach to early-onset Parkinsonism
Early-onset parkinsonism (EO parkinsonism), defined as subjects with disease onset before
the age of 40 or 50 years, can be the main clinical presentation of a variety of conditions that …
the age of 40 or 50 years, can be the main clinical presentation of a variety of conditions that …